Tools

LEADER 02725cam 2200517 a 4500

001 ocm38469061;

003 OCoLC;

005 20150728095817.0;

008 980331s1997 dcua b f000 0 eng c;

010 a| 98133428;

020 a| 0160559618;

020 a| 9780160559617;

029 1 a| AU@b| 000013851007;

035 a| (Sirsi) o38469061;

035 a| (OCoLC)38469061;

043 a| n-us---;

049 a| ERE#;

050 00 a| KF27b| .G663 1996j;

074 a| 1016-A;

074 a| 1016-B (MF);

086 0 a| Y 4.G 74/7:OF 2/6;

245 10 a| Off-label drug use and FDA review of supplemental drug applications :b| hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.;

260 a| Washington :b| U.S. G.P.O. :b| For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,c| 1997.;

300 a| iii, 152 pages :b| illustrations ;c| 24 cm;

336 a| textb| txt2| rdacontent;

337 a| unmediatedb| n2| rdamedia;

338 a| volumeb| nc2| rdacarrier;

500 a| Distributed to some depository libraries in microfiche.;

500 a| Shipping list no.: 97-0120-P.;

504 a| Includes bibliographical references.;

650 0 a| Drugsx| Prescribingz| United States.=| ^A1001069;

650 0 a| Drugsx| Labelingz| United States.=| ^A854116;

610 10 a| United States.b| Food and Drug Administration.=| ^A1253;

650 7 a| Drugsx| Labeling.2| fast0| (OCoLC)fst00898826;

650 7 a| Drugsx| Prescribing.2| fast0| (OCoLC)fst00898867;

651 7 a| United States.2| fast0| (OCoLC)fst01204155?| UNAUTHORIZED;

776 08 i| Online version:a| United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.t| Off-label drug use and FDA review of supplemental drug applications.d| Washington : U.S.G.P.O. : For sale by the U.S.G.P.O., Supt. of Docs., Congressional Sales Office, 1997w| (OCoLC)652419830;

938 a| Baker and Taylorb| BTCPn| 98133428;

994 a| C0b| ERE;

596 a| 1;

998 a| 675729;

999 a| Y 4.G 74/7:OF 2/6w| SUDOCc| 1i| 30372016691245l| JDOSm| JOYNERr| Ys| Yt| JDOSBKu| 5/26/2015x| BOOKz| JFEDDOCSo| .STAFF. jmpl;

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.

Author/creator	United States
Format	Book
Publication Info	Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997.
Description	iii, 152 pages : illustrations ; 24 cm
Subjects	United States. Food and Drug Administration. Drugs--Prescribing. --United States. Drugs--Labeling. --United States.

General note	Distributed to some depository libraries in microfiche.
General note	Shipping list no.: 97-0120-P.
Bibliography note	Includes bibliographical references.
Issued in other form	Online version: United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations. Off-label drug use and FDA review of supplemental drug applications. Washington : U.S.G.P.O. : For sale by the U.S.G.P.O., Supt. of Docs., Congressional Sales Office, 1997
LCCN	98133428
ISBN	0160559618
ISBN	9780160559617
GPO item number	1016-A
GPO item number	1016-B (MF)
Govt. docs number	Y 4.G 74/7:OF 2/6

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.

Click here for more information about this title